Evaluation of Allergy Drug Status

Health care officials, pharmaceutical industry representatives, and members of the public commented on proposals by the Food and Drug Admini… read more

Health care officials, pharmaceutical industry representatives, and members of the public commented on proposals by the Food and Drug Administration to approve several prescription allergy drugs for over-the-counter sale. Among the issues addressed were the brief time spent testing the drugs, the amount of peer review, drug pricing, and public safety. close

Report Video Issue

People in this video

  • Andrea Apter Physician University of Pennsylvania Hospital->Pulmonary, Allergy and Critical Care
  • James Barainuk Physician Georgetown University->Rheumatology, Immunoy and Allergy Division
  • George Blewitt Physician Consumer Healthcare Products Association
  • Eric Brass Physician U.S. Food and Drug Administration
  • Frank Brocato President and CEO Employers Health Coalition
  • Louis Cantilena Physician Uniformed Services University of the Health Sciences
  • Richard Carson Panelist Asthma and Allergy Foundation of America
  • Leslie Clapp Pediatrician Buffalo, NY
  • Mark Cloutier Vice President Bioethics Consultation Group
  • Ralph D'Agostino Professor Boston University->Mathematics
  • Mark Dykewicz Physician St. Louis University->School of Medicine
  • Ivor Emmanuel Physician University of California, San Francisco->Otolaryngology
  • Robert Fink Physician Children's National Health System->Pulmonary Medicine
  • Jean Ford Physician Columbia University->College of Physicians and Surgeons
  • Steve Francesco President Francesco International
  • Charles Ganley Director U.S. Food and Drug Administration->Nonprescription Drugs Cmte.
  • Edwin Gilliam Family Nurse Practitioner Coolidge, Arizona
  • Joel Hay Panelist University of Southern California->Pharmaceutical Economics and Policy
  • Daniel Hussar Professor Philadelphia College of Pharmacy
  • John Jenkins Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
  • Jesse Joad Physician University of California, Davis
  • Julie Johnson Associate Professor University of Florida->Pharmacy
  • Michael Kaliner Vice President World Allergy Association
  • William H. Kelly Professor University of New Mexico->Pharmacy and Pediatrics
  • Jack Kern Professor University of Southern California->School of Pharmacy
  • Edward Krenzelok Director Pittsburg Poison Center
  • Y.W. Francis Lam Panelist University of Texas at San Antonio->Health Science Center
  • Bobby Lanier Physician American Academy of Asthma, Allergy and Immunology
  • Bryan Luce Panelist MEDTAP International
  • Cazemiro Martin Panelist U.S. Food and Drug Administration
  • Robert Meyer M.D. Physician U.S. Food and Drug Administration
  • Francois Nader Physician Medical and Regulatory Affairs
  • Richard Neill Assistant Professor University of Pennsylvania->College of Medicine
  • Michael Nichol Professor University of Southern California->School of Pharmacy
  • Michael Niederman Physician Winthrop-Univ. Hospital Mineola, New York->Pulmonary and Critical Care
  • Michael Parker Physician American Academy of Otolaryngic Allergy
  • J.A. Quell Physician Hispanic American Allergy, Asthma and Immunology Association
  • Dan Roden Physician Vanderbilt University->School of Medicine
  • Hari Sachs Pediatrician Rockville, MD
  • Nancy Sander Founder Asthma and Allergy Network
  • Eric Schenkel Physician Valley Asthma and Treatment Center
  • Robert Seidman Vice President WellPoint Health Networks
  • Robert Spiegel Physician Schering Plough Research Institute->Medical Affairs Division
  • Bert Spilker Physician Pharmaceutical Research and Manufacturers of America
  • Sandra Titus Executive Secretary Nonprescription Drugs Advisory Committee
  • Anne Trontell Physician U.S. Food and Drug Administration->Drug Risk Evaluation
  • Donald Uden Associate Professor University of Minnesota->Pharmacy
  • William M. Vollmer Senior Investigator Kaiser Permanente->Center for Health Research
  • Alastair J. J. Wood M.D. Professor Vanderbilt University->School of Medicine
More People

Hosting Organization

More information about

Evaluation of Allergy Drug Status

563 Views
Program ID:
164202-1
Category:
Public Affairs Event
Format:
Joint Meeting
Location:
Gaithersburg, Maryland, United States
First Aired:
May 12, 2001 | 12:01am EDT | C-SPAN 2
Last Aired:
May 14, 2001 | 9:29pm EDT | C-SPAN 2

Airing Details

  • May 12, 2001 | 12:01am EDT | C-SPAN 2
  • May 14, 2001 | 10:30am EDT | C-SPAN 3
  • May 14, 2001 | 4:00pm EDT | C-SPAN 3
  • May 14, 2001 | 9:29pm EDT | C-SPAN 2
Purchase a Download

Evaluation of Allergy Drug Status

  • MP3 audio - Standard
    Price:
    $0.99
    Request Download

User Created Clips from This Video